Director's Messages
Recently, I announced the initial results of the Systolic Blood Pressure Intervention Trial (SPRINT), a clinical trial sponsored by the National Institutes of...
Each June, World Sickle Cell Day offers NHLBI a chance to reflect on our ongoing commitment to improving the lives of those living with this devastating blood...
I am pleased to announce that the NHLBI has launched a Strategic Visioning process to gather ideas for the most compelling scientific priorities to address over...
When NIH researchers talk about genome-wide association studies (GWAS), they’re often talking about research that compares DNA markers across the genome in...
When Dr. Bernadine Healy passed away in 2011, she left behind a legacy of bolstering biomedical research on women’s health. While Director of the NIH, she...
During an 1854 lecture at the University of Lille, French microbiologist and chemist Louis Pasteur said, “In the fields of observation chance favors only the...
As web-surfing consumers, we know that potentially every online search or purchase is being tracked, mined and analyzed as ‘big data’ that retailers use to...
When you speak with Dr. Joseph Loscalzo about the new Boston Biomedical Innovation Center, you can’t help but get excited about the prospects of enhancing the...
In June, the NHLBI announced in an essay published in Circulation and the Journal of the American College of Cardiology that the Institute was focusing its...
From Health Disparities in Asthma to the Microbiome, Clinician-Scientist Explores the Cutting Edge of Lung Research Estimates place the number of people...
Clinician-scientist sets sickle cell research agenda by engaging with the community, listening to families and patients More than 30 years ago, the NHLBI funded...
To further our commitment to investigator-initiated research and Early Stage Investigators (ESIs), I am pleased to inform you that the Institute is now...